दवाओं की अंतःक्रिया
Betibeglogene autotemcel + Raltegravir
गंभीरता: गंभीर
Betibeglogene autotemcel and Raltegravir: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Antiretrovirals can impair the lentiviral transduction needed to manufacture this gene therapy. Residual raltegravir in the patient at apheresis could lead to a failed or less effective product.
इस इंटरैक्शन का सरल भाषा में अर्थ
Betibeglogene autotemcel and Raltegravir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
ऐसा क्यों होता है
Antiretroviral activity inhibits lentiviral vector integration in collected cells.
क्या करें
Discontinue raltegravir at least one month before mobilization and until all apheresis cycles are finished. Confirm an appropriate interim HIV plan with an infectious disease specialist.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Betibeglogene autotemcel और Raltegravir की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Raltegravir के अन्य इंटरैक्शन
- Elvitegravir / cobicistat / emtricitabine / tenofovir df + Raltegravir निषिद्ध
- Aluminum hydroxide / magnesium carbonate + Raltegravir गंभीर
- Aluminum hydroxide / magnesium trisilicate + Raltegravir गंभीर
- Aluminum hydroxide + Raltegravir गंभीर
- Atidarsagene autotemcel + Raltegravir गंभीर
- Cabotegravir + Raltegravir गंभीर
अक्सर पूछे जाने वाले प्रश्न
Can I take Betibeglogene autotemcel with Raltegravir?
MediHelp rates the interaction as major. Betibeglogene autotemcel and Raltegravir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Antiretrovirals can impair the lentiviral transduction needed to manufacture this gene therapy. Residual raltegravir in the patient at apheresis could lead to a failed or less effective product.
How serious is the interaction between Betibeglogene autotemcel and Raltegravir?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Discontinue raltegravir at least one month before mobilization and until all apheresis cycles are finished. Confirm an appropriate interim HIV plan with an infectious disease specialist.
What other medicines interact with Raltegravir?
MediHelp also lists interactions of Raltegravir with, for example, Elvitegravir / cobicistat / emtricitabine / tenofovir df, Aluminum hydroxide / magnesium carbonate, Aluminum hydroxide / magnesium trisilicate. The full list is on the Raltegravir page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
